Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Options
BORIS DOI
Date of Publication
November 22, 2024
Publication Type
Article
Division/Institute
Contributor
Tusch, Erich | |
Ryom, Lene | |
Pelchen-Matthews, Annegret | |
Mocroft, Amanda | |
Elbirt, Daniel | |
Oprea, Cristiana | |
Günthard, Huldrych F | |
Zangerle, Robert | |
Suarez, Isabelle | |
Vehreschild, Jörg Janne | |
Wit, Ferdinand | |
Menozzi, Marianna | |
d'Arminio Monforte, Antonella | |
Spagnuolo, Vincenzo | |
Pradier, Christian | |
Carlander, Christina | |
Suanzes, Paula | |
Wasmuth, Jan-Christian | |
Carr, Andrew | |
Petoumenos, Kathy | |
Borgans, Frauke | |
Bonnet, Fabrice | |
De Wit, Stephane | |
El-Sadr, Wafaa | |
Neesgaard, Bastian | |
Jaschinski, Nadine | |
Greenberg, Lauren | |
Hosein, Sean R | |
Gallant, Joel | |
Vannappagari, Vani | |
Young, Lital | |
Sabin, Caroline | |
Lundgren, Jens | |
Peters, Lars | |
Reekie, Joanne |
Subject(s)
Series
Clinical infectious diseases
ISSN or ISBN (if monograph)
1537-6591
Publisher
Oxford University Press
Language
English
Publisher DOI
PubMed ID
38663013
Uncontrolled Keywords
Description
BACKGROUND
Mortality among people with HIV declined with the introduction of combination antiretroviral therapy. We investigated trends over time in all-cause and cause-specific mortality in people with HIV from 1999-2020.
METHODS
Data were collected from the D:A:D cohort from 1999 through January 2015 and RESPOND from October 2017 through 2020. Age-standardized all-cause and cause-specific mortality rates, classified using Coding Causes of Death in HIV (CoDe), were calculated. Poisson regression models were used to assess mortality trends over time.
RESULTS
Among 55716 participants followed for a median of 6 years (IQR 3-11), 5263 participants died (crude mortality rate [MR] 13.7/1000 PYFU; 95%CI 13.4-14.1). Changing patterns of mortality were observed with AIDS as the most common cause of death between 1999- 2009 (n = 952, MR 4.2/1000 PYFU; 95%CI 4.0-4.5) and non-AIDS defining malignancy (NADM) from 2010 -2020 (n = 444, MR 2.8/1000 PYFU; 95%CI 2.5-3.1). In multivariable analysis, all-cause mortality declined over time (adjusted mortality rate ratio [aMRR] 0.97 per year; 95%CI 0.96, 0.98), mostly from 1999 through 2010 (aMRR 0.96 per year; 95%CI 0.95-0.97), and with no decline shown from 2011 through 2020 (aMRR 1·00 per year; 95%CI 0·96-1·05). Mortality due all known causes except NADM also declined over the entire follow-up period.
CONCLUSION
Mortality among people with HIV in the D:A:D and/or RESPOND cohorts decreased between 1999 and 2009 and was stable over the period from 2010 through 2020. The decline in mortality rates was not fully explained by improvements in immunologic-virologic status or other risk factors.
Mortality among people with HIV declined with the introduction of combination antiretroviral therapy. We investigated trends over time in all-cause and cause-specific mortality in people with HIV from 1999-2020.
METHODS
Data were collected from the D:A:D cohort from 1999 through January 2015 and RESPOND from October 2017 through 2020. Age-standardized all-cause and cause-specific mortality rates, classified using Coding Causes of Death in HIV (CoDe), were calculated. Poisson regression models were used to assess mortality trends over time.
RESULTS
Among 55716 participants followed for a median of 6 years (IQR 3-11), 5263 participants died (crude mortality rate [MR] 13.7/1000 PYFU; 95%CI 13.4-14.1). Changing patterns of mortality were observed with AIDS as the most common cause of death between 1999- 2009 (n = 952, MR 4.2/1000 PYFU; 95%CI 4.0-4.5) and non-AIDS defining malignancy (NADM) from 2010 -2020 (n = 444, MR 2.8/1000 PYFU; 95%CI 2.5-3.1). In multivariable analysis, all-cause mortality declined over time (adjusted mortality rate ratio [aMRR] 0.97 per year; 95%CI 0.96, 0.98), mostly from 1999 through 2010 (aMRR 0.96 per year; 95%CI 0.95-0.97), and with no decline shown from 2011 through 2020 (aMRR 1·00 per year; 95%CI 0·96-1·05). Mortality due all known causes except NADM also declined over the entire follow-up period.
CONCLUSION
Mortality among people with HIV in the D:A:D and/or RESPOND cohorts decreased between 1999 and 2009 and was stable over the period from 2010 through 2020. The decline in mortality rates was not fully explained by improvements in immunologic-virologic status or other risk factors.
File(s)
File | File Type | Format | Size | License | Publisher/Copright statement | Content | |
---|---|---|---|---|---|---|---|
ciae228.pdf | text | Adobe PDF | 975.17 KB | publisher | accepted |